| Dr Kaitlin Dougherty, MD | |
|
988102 Nebraska Medical Center, Omaha, NE 68198-8102 | |
| (402) 559-6195 | |
| Not Available |
| Full Name | Dr Kaitlin Dougherty |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 6 Years |
| Location | 988102 Nebraska Medical Center, Omaha, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609367275 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 33392 (Nebraska) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Nebraska Medical Center | Omaha, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Unmc Physicians | 6002728391 | 1320 |
News Archive
NeoMatrix, Inc., developers of the innovative HALO® Breast Pap Test, has been awarded a new technology agreement by Novation, the supply contracting company of VHA Inc, University HealthSystem Consortium (UHC) and Provista.
GE Healthcare, a unit of the General Electric Company, today presented interim phase 2 study results of fluciclatide, in collaboration with the National Cancer Institute, a federal research agency and part of the National Institutes of Health. Fluciclatide is an integrin-targeted radiopharmaceutical under development for oncology PET imaging.
A new study of a 2008 expansion of Oregon's Medicaid program showed those with new coverage used emergency rooms 40 percent more often than other adults, throwing some water on the long-held argument that expanding Medicaid coverage lowers ER usage and boosts primary care visits.
Sodexo (PARIS:SW) (OTCBB:SDXAY), world leader in Quality of Life solutions, announced today the creation of the "Better Tomorrow Plan," designed to better respond to the challenges of proper Nutrition, Health and Wellness, Local communities and Environment.
› Verified 4 days ago
| Entity Name | Unmc Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417912114 PECOS PAC ID: 6002728391 Enrollment ID: O20031104000664 |
News Archive
NeoMatrix, Inc., developers of the innovative HALO® Breast Pap Test, has been awarded a new technology agreement by Novation, the supply contracting company of VHA Inc, University HealthSystem Consortium (UHC) and Provista.
GE Healthcare, a unit of the General Electric Company, today presented interim phase 2 study results of fluciclatide, in collaboration with the National Cancer Institute, a federal research agency and part of the National Institutes of Health. Fluciclatide is an integrin-targeted radiopharmaceutical under development for oncology PET imaging.
A new study of a 2008 expansion of Oregon's Medicaid program showed those with new coverage used emergency rooms 40 percent more often than other adults, throwing some water on the long-held argument that expanding Medicaid coverage lowers ER usage and boosts primary care visits.
Sodexo (PARIS:SW) (OTCBB:SDXAY), world leader in Quality of Life solutions, announced today the creation of the "Better Tomorrow Plan," designed to better respond to the challenges of proper Nutrition, Health and Wellness, Local communities and Environment.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kaitlin Dougherty, MD 3707 Davenport St Apt 210, Omaha, NE 68131-2437 Ph: () - | Dr Kaitlin Dougherty, MD 988102 Nebraska Medical Center, Omaha, NE 68198-8102 Ph: (402) 559-6195 |
News Archive
NeoMatrix, Inc., developers of the innovative HALO® Breast Pap Test, has been awarded a new technology agreement by Novation, the supply contracting company of VHA Inc, University HealthSystem Consortium (UHC) and Provista.
GE Healthcare, a unit of the General Electric Company, today presented interim phase 2 study results of fluciclatide, in collaboration with the National Cancer Institute, a federal research agency and part of the National Institutes of Health. Fluciclatide is an integrin-targeted radiopharmaceutical under development for oncology PET imaging.
A new study of a 2008 expansion of Oregon's Medicaid program showed those with new coverage used emergency rooms 40 percent more often than other adults, throwing some water on the long-held argument that expanding Medicaid coverage lowers ER usage and boosts primary care visits.
Sodexo (PARIS:SW) (OTCBB:SDXAY), world leader in Quality of Life solutions, announced today the creation of the "Better Tomorrow Plan," designed to better respond to the challenges of proper Nutrition, Health and Wellness, Local communities and Environment.
› Verified 4 days ago
Tyler Christian Pedersen, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 981150 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-6802 | |
Chad E Branecki, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 988095 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-9800 Fax: 402-559-9840 | |
Dr. Robert S. Devin, M.D. Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 6901 N 72nd St, Omaha, NE 68122 Phone: 402-572-2225 Fax: 402-572-4974 | |
Dr. Kevin Michael Montgomery, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 981150 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-6802 | |
Ryan Jorgenson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 981150 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-6802 | |
Phillip Marshall Stratton, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 8303 Dodge St, Omaha, NE 68114 Phone: 402-354-4424 Fax: 402-354-4435 | |
Dr. James E Quinn, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 8303 Dodge St, Omaha, NE 68114 Phone: 402-354-4424 Fax: 402-354-4435 |